Market Positioning Target AMAG as a licensed partner for specialty therapies and clinical research collaborations given their focus on complex, underserved conditions and active engagement with doctors, specialists, and patient advocates.

Therapeutic Expansion Leverage AMAG’s portfolio including Intrarosa and other innovative medicines to propose co-development, lifecycle management, or access programs that expand patient reach and payer coverage in menopause-related therapies.

Clinical Collaboration Propose clinical research partnerships and real-world evidence generation with AMAG’s emphasis on investing in clinical studies to broaden knowledge, potentially accelerating adoption and market access.

Funding & M&A Position ourselves as a strategic investor or services partner to support AMAG’s growth post-acquisition by Covis, including integration services, commercialization support, and operational scalability.

Compliance & Risk Offer risk management, governance, and regulatory affairs services to navigate potential securities and fiduciary concerns disclosed in prior periods, ensuring clean post-merger integration and investor confidence.